Related Experiment Video
Updated: Jul 8, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
EZH1/2 alteration as a potential biomarker for immune checkpoint inhibitors across multiple cancer types
Huageng Huang1, Xinyi Deng2, Le Yu3
1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Journal of Translational Medicine
|December 16, 2023
Abstract
No abstract available in PubMed .

